No­var­tis eyes a new mar­ket with its buy­out of a small dig­i­tal ther­a­peu­tics play­er

No­var­tis has scooped up a dig­i­tal ther­a­peu­tics play­er work­ing on a new treat­ment for lazy eye.

The com­pa­ny is Phoenix-based Am­bly­otech, which has been pur­su­ing work on a com­bi­na­tion gam­ing and video ap­proach to train­ing eyes to work to­geth­er. But the buy­er and pri­vate sell­er are keep­ing the terms to them­selves.

The soft­ware they de­vel­oped “em­ploys a unique vi­su­al pre­sen­ta­tion, called di­chop­tic dis­play, where each eye is pre­sent­ed with a dif­fer­ent im­age us­ing a pro­pri­etary al­go­rithm to ob­tain co-op­er­a­tion with both eyes work­ing to­geth­er to view a full im­age.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER